Skip to main content

Table 1 Baseline characteristics of the study population

From: The prevalence of increased serum IgE and Aspergillus sensitization in patients with COPD and their association with symptoms and lung function

Variables

Patients with COPD(273 cases)

Male, n(%)

174(63)

Age (yr)

77(8,51 ~ 90)

Risk factors

 

Smokers, n(%)

224(82)

Smoking index (pack-yr)

43(23,10 ~ 120)

Biomass fuel exposure, n(%)

42(15)

Biomass fuel exposure history (yr)

27(7,10 ~ 40)

Occupational dust exposure, n(%)

37(14)

Occupational dust exposure history (yr)

25(10,10 ~ 40)

History of chronic cough/sputum (yr)

19(12,2 ~ 50)

History of dyspnea (yr)

6.1(5.0,0 ~ 20)

Ratio of dyspnea history to chronic cough/sputum history

0.32(0.21,0 ~ 1)

Occurrence of wheezing, n(%)

214(78)

FEV1/FVC%

46(11,22 ~ 69)

FEV1%predicted

41(13,14 ~ 79)

GOLD stage

 

Stage II, n(%)

73(26.8)

Stage III, n(%)

131(47.9)

Stage IV, n(%)

69(25.3)

Serum T-IgE (kU/L)

401(916,2 ~ 7420)

  1. Continuous data expressed as mean (standard deviation, range).
  2. Categorical data expressed as number (percentage).
  3. Definition of abbreviations: FEV1: Forced expiratory volume in 1 second, FVC: Forced vital capacity.